Publix to open pharmacy at Moffitt Cancer Center
LAKELAND, Fla. — Publix will open an expanded access, full-service retail pharmacy at the Moffitt Cancer Center in Tampa, Fla., on July 2.
Currently, Moffitt’s retail pharmacy offers specialized convenience to patients treated at Moffitt on an outpatient basis, Moffitt employees and their dependents, and other cancer center visitors, Moffitt said. The Publix pharmacy at Moffitt will continue to provide excellent customer service to patients and will be able to expand services including:
Pickup of prescriptions at their neighborhood Publix pharmacy;
Ease of refilling prescriptions at multiple convenient locations;
Electronic routing of prescriptions to desired neighborhood Publix pharmacy locations; and
Expanded hours through their neighborhood Publix pharmacy and the Publix pharmacy at Moffitt.
“Publix pharmacies have been dedicated to the health and wellness needs of our customers and their families,” Publix VP pharmacy operations Fred Ottolino said. “The opportunity to bring our level of customer care to patients of Moffitt Cancer Center not only allows us to meet their immediate needs, but also to build long-term relationships with our customers as they return home.”
No comments found
FDA approves Biogen Idec’s Avonex Pen, dose titration regimen
WESTON, Mass. — The Food and Drug Administration has approved two separate dosing innovations for multiple sclerosis patients that are being treated with a Biogen Idec drug.
Biogen Idec said the FDA approved Avonex pen, the first single-use, once-weekly intramuscular autoinjector approved for MS, and a dose titration regimen, which gradually escalates the dose of Avonex at treatment initiation. The drug maker said the new offerings are designed to improve the treatment experience.
The Avonex pen incorporates a smaller needle and easier administration to help patients reduce anxiety about self-injection, reduces the incidence and severity of flu-like symptoms that can occur at the beginning of therapy.
No comments found
U.S. News & World Report lists pharmacist as a top job for 2012
NEW YORK — Pharmacists should see significant growth over the next decade, making the profession one of the top jobs for 2012, according to U.S. News & World Report magazine.
The publication said the occupation of a pharmacist earned the No. 3 spot on its ‘The Best Jobs of 2012’ list. The magazine cited solid employment growth — a projected 25.4% employment growth for pharmacists between 2010 and 2020, with the field adding 69,700 new jobs, according to the Bureau of Labor Statistics — along with other such key factors as the aging population, increase need for complex medicines and medication therapy management.
Salary was another factor that prompted pharmacist to earn its spot on the list: according to the Labor Department, U.S. News said, the median annual salary for a pharmacist was $111,570 in 2010. The best-paid 10% made approximately $138,620 a year, while the lowest-paid made approximately $82,090.
Click here to read the full profile.